1. An elevated lipoprotein(a) plasma level as a cardiovascular risk factor. (May 2015) Authors: Tselmin, S.; Müller, G.; Gelgaft, E.; Fischer, S.; Julius, U. Journal: Atherosclerosis Issue: Volume 18(2015) Page Start: 257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cardiovascular events in patients treated by lipoprotein apheresis (LA) – Analysis of possible reasons. (September 2016) Authors: Tselmin, S.; Fischer, S.; Pistrosch, F.; Müller, G.; Julius, U. Journal: Atherosclerosis Issue: Volume 252(2016) Page Start: e215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Current insights into the German Lipoprotein Apheresis Registry (GLAR) – Almost 5 years on. (November 2017) Authors: Vogt, A.; Jaeger, B.R.; van Buuren, F.; Mellwig, K.P.; Klör, H.U.; Grützmacher, P.; Roeseler, E.; Julius, U.; Heigl, F.; Blume, H.; Schettler, V.J.J.; Neumann, C.L.; Peter, C.; Zimmermann, T.; Julius, U.; Roeseler, E.; Heigl, F.; Grützmacher, P.; Blume, H. Journal: Atherosclerosis Issue: Volume 30(2017) Page Start: 50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Current insights into the German lipoprotein apheresis standard: PCSK9-inhibitors, lipoprotein apheresis or both?. (November 2017) Authors: Schettler, V.J.J.; Ringel, J.; Jacob, S.; Julius, U.; Klingel, R.; Heigl, F.; Roeseler, E.; Grützmacher, P. Journal: Atherosclerosis Issue: Volume 30(2017) Page Start: 44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Detailed description of the cardiovascular situation in patients who have started lipoprotein apheresis treatment. (May 2015) Authors: Schampera, S.; Fischer, S.; Weiss, N.; Julius, U. Journal: Atherosclerosis Issue: Volume 18(2015) Page Start: 209 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Effects of different lipoprotein apheresis methods on serum protein levels. (May 2015) Authors: Julius, U.; Siegert, G.; Kostka, H.; Schatz, U.; Hohenstein, B. Journal: Atherosclerosis Issue: Volume 18(2015) Page Start: 95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Effects of lipoprotein apheresis on PCSK9 levels. (May 2015) Authors: Julius, U.; Milton, M.; Stoellner, D.; Rader, D.; Gordon, B.; Polk, D.; Waldmann, E.; Parhofer, K.G.; Moriarty, P.M. Journal: Atherosclerosis Issue: Volume 18(2015) Page Start: 180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Effects of Lipoprotein apheresis on the Lipoprotein(a) levels in the long run. (May 2015) Authors: Groß, E.; Hohenstein, B.; Julius, U. Journal: Atherosclerosis Issue: Volume 18(2015) Page Start: 226 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Elevated lipoprotein(a) levels result in a high cardiovascular risk – A prospective analysis of a lipidology outpatients unit. (September 2016) Authors: Schatz, U.; Fischer, S.; Julius, U.; Bornstein, S.R.; Tselmin, S. Journal: Atherosclerosis Issue: Volume 252(2016) Page Start: e127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. First on-line survey of an international multidisciplinary working group (MightyMedic) on current practice in diagnosis, therapy and follow-up of dyslipidemias. (May 2015) Authors: Stefanutti, C.; D'Alessandri, G.; Petta, A.; Harada-Shiba, M.; Julius, U.; Soran, H.; Moriarty, P.M.; Romeo, S.; Drogari, E.; Jaeger, B.R. Journal: Atherosclerosis Issue: Volume 18(2015) Page Start: 241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗